PKM and breast cancer: To assess whether the status of PKM2 expression affected how BC cells responded to conventional chemotherapeutic, cisplatin, we compared the proliferation capability of PKM2-expressing T24 cells with PKM2-knockdown T24 cells (Fig. 2A) in the presence of 1 μg/ml cisplatin.